Trial Profile
A Study to Evaluate the Impact of Empiric Use of Linezolid on Mortality in Vancomycin Resistant Enterococcus Spp-Colonized Hematology and Hematopoietic Stem Cell Transplantation Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2016
Price :
$35
*
At a glance
- Drugs Linezolid (Primary)
- Indications Vancomycin-resistant enterococcal infections
- Focus Therapeutic Use
- 11 May 2016 New trial record